Exporting Equines to New Caledonia

9 July 2008

horaniec.nca

You are viewing animal export requirements. They outline overseas country requirements for live animal and animal germplasm (semen and embryos) exported from New Zealand.

The document is also available as a PDF: horaniec.nca (25 KB)
Information on viewing PDF files

Overseas Market Access Requirements Notification - Animal Products Act 1999 - MAF Biosecurity New Zealand

Exports to New Caledonia Notice

The New Caledonian Government will re-open their government quarantine on the 18 May 2008.

Entry of cattle into the country will not be accepted until further notice but all other exports can resume after 18 May.

Ref: AE-NC 13L

1. Statutory authority

Pursuant to section 60 of the Animal Products Act 1999:

(i) I notify the following overseas market access requirements, entitled equines to New Caledonia

(ii) Revoke OMAR B HORANIEC.NCA 08.01.08.

This notice takes effect from date of signing.

Dated at Wellington this 21st day of July 2008.

Signed: Tim Knox
Director
Border Standards
MAF Biosecurity New Zealand
(pursuant to delegated authority)

2. New Caledonia Requirements

Equines exported from New Zealand to New Caledonia must comply with the import regulations of New Caledonia listed in this notice as follows.

2.1 An import permit is required for the exportation of equines to New Caledonia..

2.2 An official veterinarian authorised by the New Zealand Ministry of Agriculture and Forestry must certify, after due enquiry, the following:

2.2.1 New Zealand is free of rabies, equine encephalomyelitis (Eastern and Western, and Venezuelean, Japanese encephalitis, African horse sickness, dourine, glanders, piroplasmosis (Babesia equi, Babesia caballi), contagious equine metritis, equine influenza (type A), melioidosis, anthrax, epizootic lymphangitis, and Salmonella abortus equi.

2.2.2.1 Either: the animals were born in and remained continuously in New Zealand or in Australia, and have been living in New Zealand for at least 6 months.

2.2.2.2 Or: the animals were imported into New Zealand from the European Union and for the past 30 days have remained in quarantine/isolation, with no quarantine/isolation break since they were imported.

2.2.3 The animals for export have not been present on any premises declared to be a restricted place (Biosecurity Act 1993, section 130) for equine infectious anaemia, nor had contact with horses from such premises.

2.2.4 No clinical evidence of blackleg and equine herpes virus (EHV type I) has been diagnosed on the properties where the animals have been resident during the 6 months prior to the scheduled date of shipment.

2.2.5 The animals were isolated for at least 30 days prior to the date of embarkation, and during this time they were subjected to the following tests with negative results in each case:

2.2.5.1 agar gel immunodiffusion (AGID - Coggins) test for equine infectious anaemia.

Date of sampling

2.2.5.2 a complement fixation (CF) test for brucellosis (Brucella abortus) (negative is a titre <20 ICFTU/ml). Date of sampling.

2.2.6 Within 30 days of shipment, the animals were:

2.2.6.1 either submitted to the microscopic-agglutination test (MAT) for leptospirosis and reacted less than 1/100 to the following serotypes (australis, autumnalis, ballum, canicola, grippotyphosa, hebdomadis, icterohaemorrhagiae, pomona, sejroe, and tarassovi)

2.2.6.2 or were treated twice with dihydrostreptomycin 25 mg/kg, 14 days apart. Dates of treatment

2.2.6.3 or were treated with another registered antibiotic that is effective against leptospirosis. Type of antibiotic administered and dose rate. Date(s) of treatment.

2.2.7 Within 48 hours prior to the scheduled date of shipment, they were treated for external and internal parasites with parasiticides and using methods approved by the veterinary authorities of the Government of New Zealand. Date of treatment. Type of parasiticide administered, method of application and dose rate to be recorded.

2.2.8 As far as it can be ascertained, the animals have been vaccinated. Type and name of vaccine administered. Date vaccinated.

2.2.9 The animals were transported directly from the properties of origin to the port of embarkation in cleaned and disinfected vehicles. During the transport, the animals were completely isolated from any other animals of a different health status.

2.2.10 Prior to scheduled shipments, the Official Veterinarian of the Government of New Zealand has examined each animal and found them to be in good health and free from any clinical evidence of strangles, equine viral rhinopneumonitis, and all other contagious and infectious diseases.

3. Definitions

For the purposes of this document:

Any term or expression that is defined in the Animal Products Act 1999 and used, but not defined in this document, has the same meaning as in this Act.

Explanatory note

These overseas market access requirements are based on the current export certificate for equines to New Caledonia dated 9 July 2008.

Additional Information for OMAR Notification: HORANIEC.NCA 09.07.08

1. This OMAR replaces the one dated 8 January 2008.

2. Official Veterinarian means a civil veterinarian or a specially appointed veterinarian, as authorised by the New Zealand Ministry of Agriculture and Forestry.

3. In relation to clause 2.2.3 for EIA, horses for export must not have been present on a Restricted Place from the 24 May 1999 until revocation of the Restricted Place notice, nor had contact with horses from such premises.

4. Mares more than 9 months pregnant at the estimated date of arrival in New Caledonia are not allowed to be shipped. A pregnancy certificate must be enclosed with the export certificate.

5. This export certificate is applicable to both horses and donkeys.

Section 61.A of the Animal Products Amendments Act 2005 states that 'The Crown is not liable, and nor is the Director-General or any employee of the Ministry liable, for any loss arising through the refusal or failure of the relevant authority of an overseas market to admit export animal material or animal product to that market'.